Unlisted holdings

Data as at : 01/12/2023

% of total assets
6.3

Please note that the percentage of unlisted holdings is displayed for companies that have reported this data to the AIC. “N/R” means the data has not been reported to the AIC. Where data is reported, it may be subject to valuation lags.

Top holdings

Data as at : 31/01/2024

Investment % of total assets
Eli Lilly and Co 8.0
Boston Scientific Corp 6.5
AstraZeneca PLC 5.9
Intuitive Surgical Inc 5.8
Novo Nordisk A/S Class B 5.8
Biogen Inc 4.6
Merck & Co Inc 4.1
Daiichi Sankyo Co Ltd 3.7
Tenet Healthcare Corp 3.2
Stryker Corp 3.0

Geographic breakdown

Data as at : 30/04/2024

Country % of total assets
USA 66.0
UK 9.2
Japan 6.4
Denmark 6.2
China 5.7
Ireland 1.6
Netherlands 1.4
Hong Kong 0.5
India 0.2

Depending on the nature of the underlying asset classes, geographic breakdowns may not always add up to 100%.

Industry breakdown

Data as at : 30/04/2024

Industry % of total assets
Healthcare 96.5
Preferred 6.0
Cash Equivalents 3.8
Scroll

Asset breakdown

Data as at : 30/04/2024

Asset % of total assets
Stock 102.5
Other -6.4
Cash/Cash equivalents 3.8

Detailed asset breakdown

Data as at : 30/04/2024

Asset % of total assets
North America - stock 70.6
UK - Large growth stock 7.2
Japan - stock 6.7
Europe - Large-cap stock 6.5
Preferred stock 6.0
Cash 3.8
Asia (excl Japan) - stock 3.1
UK - Large core/value stock 2.4

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.